Ascentage Pharma Group International Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Ascentage Pharma Group International Co., Ltd."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -41.44% vs 333.43% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -206.50% vs 57.00% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "622.60",
          "val2": "1,063.20",
          "chgp": "-41.44%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1,220.90",
          "val2": "-309.70",
          "chgp": "-294.22%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "58.60",
          "val2": "69.90",
          "chgp": "-16.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-29.60",
          "val2": "0.30",
          "chgp": "-9,966.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1,348.00",
          "val2": "-439.80",
          "chgp": "-206.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2,111.40%",
          "val2": "-386.30%",
          "chgp": "-172.51%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

622.60

1,063.20

-41.44%

Operating Profit (PBDIT) excl Other Income

-1,220.90

-309.70

-294.22%

Interest

58.60

69.90

-16.17%

Exceptional Items

-29.60

0.30

-9,966.67%

Consolidate Net Profit

-1,348.00

-439.80

-206.50%

Operating Profit Margin (Excl OI)

-2,111.40%

-386.30%

-172.51%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -41.44% vs 333.43% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -206.50% vs 57.00% in Dec 2024

All Annual Results